Sung-Min Ahn logo Academic Members logo

Sung-Min Ahn

Associate Professor, Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center (South Korea)


Sung-Min is currently an associate professor of Gachon University Gil Medical Center in Korea, working for Dept. of Genome Medicine and Science and for Dept. of Medical Oncology. Sung-Min received his BSc in Molecular Biology and Biochemistry from the University of Queensland. He received his M.D degree from Ajou University, and his PhD from the University of Melbourne with emphasis on genomics and proteomics. He is a member of IBM’s innovation council for oncology data and evidence. He is founder and co-CEO of ImmunoForge, which develops new cancer drugs.

Research interest: Cancer Genomics and Genomics-Driven Drug Discovery


Why WIN

1) Global networking in personalized cancer medicine
2) Participation in cutting-edge clinical trials
3) Collaboration in the development of new systems biology platform for personalized cancer medicine

Sung-Min Ahn logo

Sung-Min Ahn

Associate Professor, Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center (South Korea)


Academic Members logo

Sung-Min is currently an associate professor of Gachon University Gil Medical Center in Korea, working for Dept. of Genome Medicine and Science and for Dept. of Medical Oncology. Sung-Min received his BSc in Molecular Biology and Biochemistry from the University of Queensland. He received his M.D degree from Ajou University, and his PhD from the University of Melbourne with emphasis on genomics and proteomics. He is a member of IBM’s innovation council for oncology data and evidence. He is founder and co-CEO of ImmunoForge, which develops new cancer drugs.

Research interest: Cancer Genomics and Genomics-Driven Drug Discovery


Why WIN

1) Global networking in personalized cancer medicine
2) Participation in cutting-edge clinical trials
3) Collaboration in the development of new systems biology platform for personalized cancer medicine